You have 1 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Urothelial Bladder Cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Urothelial Carcinoma, High Risk Non-Muscle Invasive Bladder

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
  • +2 more
  • PDD-TURBT with hexaminolevulinate (Hexvix®)
  • Power Led Saphira (TM) from KARL STORZ
  • (no location specified)
Jul 24, 2023

Cisplatin-Ineligible Metastatic Bladder Cancer and The Role of

Not yet recruiting
  • Bladder Cancer
  • +3 more
  • Geriatric-8 Survey
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 14, 2023

Bladder Urothelial Carcinoma, Bladder Cancer Trial in São Paulo (Monopolar Transurethral resection of bladder tumor, Holmium

Recruiting
  • Bladder Urothelial Carcinoma
  • Bladder Cancer
  • Monopolar Transurethral resection of bladder tumor
  • Holmium Laser resection of bladder tumor (HoLEBT)
  • São Paulo, Brazil
    Instituto do Cancer do Estado de São Paulo (ICESP)
Apr 18, 2023

Avelumab in Real-World Treatment for Advanced or Metastatic

Not yet recruiting
  • Bladder Cancer
  • (no location specified)
Nov 21, 2022

Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma Trial in

Recruiting
  • Advanced Bladder Urothelial Carcinoma
  • +23 more
  • Riverside, California
  • +8 more
Jul 16, 2022

Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER

Recruiting
  • Urothelial Carcinoma
  • +2 more
    • Recife, Pernambuco, Brazil
    • +6 more
    Jul 11, 2023

    Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

    Recruiting
    • Locally Advanced Bladder Urothelial Carcinoma
    • +18 more
    • Los Angeles, California
    • +2 more
    Jun 28, 2022

    Muscle Invasive Bladder Carcinoma, Localized Cancer, Urothelial Carcinoma Trial (Pembrolizumab)

    Recruiting
    • Muscle Invasive Bladder Carcinoma
    • +2 more
    • Indianapolis, Indiana
    • +1 more
    Jan 12, 2023

    Localized Muscle Invasive Bladder Urothelial Carcinoma, Muscle-Invasive Bladder Carcinoma Trial in Cleveland (Sacituzumab

    Not yet recruiting
    • Localized Muscle Invasive Bladder Urothelial Carcinoma
    • Muscle-Invasive Bladder Carcinoma
    • Sacituzumab govitecan
    • Adaptive Radiotherapy
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Apr 18, 2023

    Bladder Urothelial Carcinoma, Urothelial Carcinoma Trial in Philadelphia (Copper Cu 64 TP3805, Positron Emission Tomography,

    Active, not recruiting
    • Bladder Urothelial Carcinoma
    • Urothelial Carcinoma
    • Copper Cu 64 TP3805
    • +2 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Dec 13, 2022

    Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma

    Recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +41 more
    • Ipilimumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 11, 2022

    Recurrent Bladder Carcinoma, Stage 0a Bladder Urothelial Carcinoma, Stage 0is Bladder Urothelial Carcinoma Trial in Chicago (BCG

    Active, not recruiting
    Has Results
    • Recurrent Bladder Carcinoma
    • +3 more
    • BCG Solution
    • +3 more
    • Chicago, Illinois
      Northwestern University
    Sep 27, 2022

    Non Muscle Invasive Bladder Cancer, Urologic Cancer, Bladder Cancer Trial (Cretostimogene Grenadenorepvec,

    Not yet recruiting
    • Non Muscle Invasive Bladder Cancer
    • +3 more
    • Cretostimogene Grenadenorepvec
    • n-dodecyl-B-D-maltoside
    • (no location specified)
    Oct 30, 2023

    Urothelial Cancer, Metastatic Urothelial Carcinoma, Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter Trial in

    Recruiting
    • Urothelial Cancer
    • +3 more
    • Sacituzumab Govitecan (SG)
    • Enfortumab vedotin-ejfv (EV)
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Sep 28, 2022

    Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

    Recruiting
    • Locally Advanced Bladder Urothelial Carcinoma
    • +13 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Jun 8, 2022

    Bladder Carcinoma, Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma Trial in Toronto (biological, procedure,

    Recruiting
    • Bladder Carcinoma
    • +7 more
    • Atezolizumab
    • +5 more
    • Toronto, Ontario, Canada
      University Health Network Princess Margaret Cancer Center LAO
    Nov 8, 2022

    Urine DNA Testing for Bladder Cancer in China

    Recruiting
    • Bladder Cancer
    • +3 more
    • Urine DNA methylation analysis
    • medical imaging and/or cystoscopy and/or pathological examination
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Dec 29, 2022

    Bladder Adenocarcinoma, Bladder Mixed Adenocarcinoma, Bladder Squamous Cell Carcinoma Trial in Palo Alto (drug, procedure,

    Active, not recruiting
    • Bladder Adenocarcinoma
    • +11 more
    • Palo Alto, California
      Stanford Cancer Institute Palo Alto
    Mar 25, 2022

    Urinary Bladder Cancer Trial in München, Ulm, Würzburg (drug, radiation, procedure)

    Active, not recruiting
    • Urinary Bladder Cancer
    • München, Germany
    • +2 more
    Oct 19, 2022

    Muscle-invasive Urothelial Carcinoma of the Bladder Trial in Milan (Pembrolizumab 25 mg/1 ML Intravenous Solution [KEYTRUDA])

    Not yet recruiting
    • Muscle-invasive Urothelial Carcinoma of the Bladder
    • Pembrolizumab 25 mg/1 ML Intravenous Solution [KEYTRUDA]
    • Milan, MI, Italy
      Fondazione San Raffaele
    Sep 8, 2022

    Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in United States (UGN-102)

    Active, not recruiting
    • Bladder Cancer
    • +2 more
    • Homewood, Alabama
    • +4 more
    Dec 15, 2022

    Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder

    Active, not recruiting
    • Advanced Clear Cell Renal Cell Carcinoma
    • +35 more
    • Cabozantinib S-malate
    • +2 more
    • Duarte, California
    • +7 more
    Jan 3, 2023

    Bladder Cancer, Non-Muscle-Invasive Urothelial Carcinoma Trial in New York (BGJ398)

    Active, not recruiting
    • Bladder Cancer
    • Non-Muscle-Invasive Urothelial Carcinoma
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Feb 3, 2022

    Advanced Urothelial Carcinoma Trial in Boston (copanlisib, Avelumab)

    Not yet recruiting
    • Advanced Urothelial Carcinoma
    • Boston, Massachusetts
      VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
    Jan 13, 2023

    Muscle Invasive Bladder Urothelial Carcinoma Trial in Saint Louis (Daily Adaptive External Beam Radiation Therapy)

    Not yet recruiting
    • Muscle Invasive Bladder Urothelial Carcinoma
    • Daily Adaptive External Beam Radiation Therapy
    • Saint Louis, Missouri
      Washington University, St. Louis
    Jan 17, 2023